US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Scribe Therapeutics, Inc.

29.41

-1.9300-6.16%

Pre-market: 30.400.9932+3.38%06:18 EDT

Volume:153.25K

Turnover:4.61M

Market Cap:516.95M

PE:-2.23

High:32.16

Open:30.59

Low:29.14

Close:31.34

52wk High:39.60

52wk Low:17.31

Shares:17.58M

Float Shares:8.62M

Volume Ratio:0.80

T/O Rate:1.78%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-13.1763

EPS(LYR):-8.9776

ROE:--

ROA:--

PB:-3.14

PE(LYR):-3.28

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Scribe Therapeutics Inc Price Target Maintained with a $60.00/Share by HC Wainwright & Co.

Scribe Therapeutics reports Q2 EPS ($2.62), consensus ($3.72)

Scribe Therapeutics Q3 EPS $(2.62) Misses $(1.05) Estimate, Sales $1.918M Miss $3.113M Estimate

Benzinga Earnings

Scribe Therapeutics Q2 FY26 Net Loss Narrows 34.34% to $6.5 Million; Revenue Falls 61.22% to $1.9 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/SCTX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCTX\",,,,,undefined,":{"symbol":"SCTX","market":"US","secType":"STK","nameCN":"Scribe Therapeutics, Inc.","latestPrice":29.41,"timestamp":1788984000000,"preClose":31.34,"halted":0,"volume":153250,"hourTrading":{"tag":"盘前","latestPrice":30.4032,"preClose":29.41,"latestTime":"06:18 EDT","volume":6,"amount":182.4192,"timestamp":1789035485572,"change":0.9932,"changeRate":0.033771,"amplitude":0},"delay":0,"changeRate":-0.06158264199106572,"floatShares":8623940,"shares":17577400,"eps":-13.17626,"marketStatus":"Pre-Mkt","change":-1.93,"latestTime":"09-10 08:19:51 EDT","open":30.59,"high":32.16,"low":29.14,"amount":4612077.29325,"amplitude":0.096362,"askPrice":38.94,"askSize":100,"bidPrice":28,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-13.17626,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"listingDate":1784865600000,"exchange":"NASDAQ","adjPreClose":29.41,"preHourTrading":{"tag":"盘前","latestPrice":30.4032,"preClose":29.41,"latestTime":"06:18 EDT","volume":6,"amount":182.4192,"timestamp":1789035485572,"change":0.9932,"changeRate":0.033771,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":29.41,"preClose":29.41,"latestTime":"19:30 EDT","volume":990,"amount":29071.89,"timestamp":1788996607085,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7981172251649751},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCTX\",,,,,undefined,":{"symbol":"SCTX","floatShares":8623940,"roa":"--","roe":"--","lyrEps":-8.977559,"volumeRatio":0.7981172251649751,"shares":17577400,"dividePrice":0,"high":32.16,"amplitude":0.096362,"preClose":31.34,"low":29.14,"week52Low":17.305,"pbRate":"-3.14","psRate":"15.52","week52High":39.6,"institutionHeld":0,"latestPrice":29.41,"eps":-13.17626,"divideRate":0,"volume":153250,"delay":0,"ttmEps":-13.17626,"open":30.59,"prevYearClose":15,"prevWeekClose":28.67,"prevMonthClose":30.54,"prevQuarterClose":15,"fiveDayClose":29,"twentyDayClose":23.44,"sixtyDayClose":15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCTX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1788235200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCTX","date":"2026-09-09","current":-2.232045,"percent":0.03125,"low":-19.666901,"twenty":-16.442585,"median":-13.41573,"eighty":-10.761095,"high":-6.340558,"avg":-13.49484,"sd":3.252188,"marketCap":593318851},"quantilePoints":[{"date":"2026-07-24","current":-7.393791,"twenty":-7.183144,"median":-6.867174,"eighty":-6.551205,"marketCap":264180150},{"date":"2026-07-31","current":-10.770598,"twenty":-10.0156,"median":-9.614342,"eighty":-7.393791,"marketCap":384833474},{"date":"2026-08-07","current":-13.41573,"twenty":-11.647029,"median":-10.284865,"eighty":-9.535147,"marketCap":479344048},{"date":"2026-08-14","current":-10.754759,"twenty":-12.565698,"median":-10.885431,"eighty":-9.693538,"marketCap":384267542},{"date":"2026-08-21","current":-17.333272,"twenty":-13.41573,"median":-11.187695,"eighty":-10.0156,"marketCap":619317792},{"date":"2026-08-28","current":-15.226669,"twenty":-16.393484,"median":-12.262115,"eighty":-10.284865,"marketCap":544048892},{"date":"2026-09-04","current":-16.266771,"twenty":-16.314288,"median":-13.162305,"eighty":-10.754759,"marketCap":581211732},{"date":"2026-09-09","current":-18.36673,"twenty":-16.442585,"median":-13.41573,"eighty":-10.761095,"marketCap":593318851}],"updateTime":1789036833645},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCTX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664879194","title":"Scribe Therapeutics Inc Price Target Maintained with a $60.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664879194","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664879194?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:24","pubTimestamp":1788434640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SCTX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664588841","title":"Scribe Therapeutics reports Q2 EPS ($2.62), consensus ($3.72)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664588841","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664588841?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:30","pubTimestamp":1788381015,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $1.92M, consensus $3.11M. “The second quarter and the weeks immediately following represented a transformational period for Scri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scribe-therapeutics-reports-q2-eps-2-62-consensus-3-72-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scribe-therapeutics-reports-q2-eps-2-62-consensus-3-72-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664284964","title":"Scribe Therapeutics Q3 EPS $(2.62) Misses $(1.05) Estimate, Sales $1.918M Miss $3.113M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2664284964","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664284964?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:10","pubTimestamp":1788379852,"startTime":"0","endTime":"0","summary":"Scribe Therapeutics (NASDAQ:SCTX) reported quarterly losses of $(2.62) per share which missed the analyst consensus estimate of $(1.05) by 149.52 percent.  The company reported quarterly sales of $1.918 million which","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61589400/scribe-therapeutics-q3-eps-2-62-misses-1-05-estimate-sales-1-918m-miss-3-113m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Scribe Therapeutics Q3 EPS $(2.62) Misses $(1.05) Estimate, Sales $1.918M Miss $3.113M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849504","title":"Scribe Therapeutics Q2 FY26 Net Loss Narrows 34.34% to $6.5 Million; Revenue Falls 61.22% to $1.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849504","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849504?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:09","pubTimestamp":1788379771,"startTime":"0","endTime":"0","summary":"Scribe Therapeutics Q2 FY26 net loss narrows 34.34% to $6.5 million; revenue falls 61.22% to $1.9 millionScribe Therapeutics posted a Q2 net loss of USD 6.5 million, narrowing from USD 9.9 million a y","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbL8P2g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SCTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SCTX\",params:#limit:6,delay:false,,,undefined,":[]}}